Thomas E Dobbs1, Alice Y Guh2, Peggy Oakes3, Mary Jan Vince3, Joseph C Forbi4, Bette Jensen2, Heather Moulton-Meissner2, Paul Byers3. 1. Mississippi State Department of Health, Jackson, MS. Electronic address: thomas.dobbs@msdh.state.ms.us. 2. Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. 3. Mississippi State Department of Health, Jackson, MS. 4. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
BACKGROUND: Four patients were hospitalized July 2011 with Pseudomonas aeruginosa bloodstream infection (BSI), 2 of whom also had Klebsiella pneumoniae BSI. All 4 patients had an indwelling port and received infusion services at the same outpatient oncology center. METHODS: Cases were defined by blood or port cultures positive for K pneumoniae or P aeruginosa among patients receiving infusion services at the oncology clinic during July 5-20, 2011. Pulsed-field gel electrophoresis (PFGE) was performed on available isolates. Interviews with staff and onsite investigations identified lapses of infection control practices. Owing to concerns over long-standing deficits, living patients who had been seen at the clinic between January 2008 and July 2011 were notified for viral blood-borne pathogen (BBP) testing; genetic relatedness was determined by molecular testing. RESULTS: Fourteen cases (17%) were identified among 84 active clinic patients, 12 of which involved symptoms of a BSI. One other patient had a respiratory culture positive for P aeruginosa but died before blood cultures were obtained. Available isolates were indistinguishable by PFGE. Multiple injection safety lapses were identified, including overt syringe reuse among patients and reuse of syringes to access shared medications. Available BBP results did not demonstrate iatrogenic viral infection in 331 of 623 notified patients (53%). CONCLUSIONS: Improper preparation and handling of injectable medications likely caused the outbreak. Increased infection control oversight of oncology clinics is critical to prevent similar outbreaks.
BACKGROUND: Four patients were hospitalized July 2011 with Pseudomonas aeruginosa bloodstream infection (BSI), 2 of whom also had Klebsiella pneumoniae BSI. All 4 patients had an indwelling port and received infusion services at the same outpatient oncology center. METHODS: Cases were defined by blood or port cultures positive for K pneumoniae or P aeruginosa among patients receiving infusion services at the oncology clinic during July 5-20, 2011. Pulsed-field gel electrophoresis (PFGE) was performed on available isolates. Interviews with staff and onsite investigations identified lapses of infection control practices. Owing to concerns over long-standing deficits, living patients who had been seen at the clinic between January 2008 and July 2011 were notified for viral blood-borne pathogen (BBP) testing; genetic relatedness was determined by molecular testing. RESULTS: Fourteen cases (17%) were identified among 84 active clinic patients, 12 of which involved symptoms of a BSI. One other patient had a respiratory culture positive for P aeruginosa but died before blood cultures were obtained. Available isolates were indistinguishable by PFGE. Multiple injection safety lapses were identified, including overt syringe reuse among patients and reuse of syringes to access shared medications. Available BBP results did not demonstrate iatrogenic viral infection in 331 of 623 notified patients (53%). CONCLUSIONS: Improper preparation and handling of injectable medications likely caused the outbreak. Increased infection control oversight of oncology clinics is critical to prevent similar outbreaks.
Authors: Melissa K Schaefer; Kiran M Perkins; Ruth Link-Gelles; Alexander J Kallen; Priti R Patel; Joseph F Perz Journal: Am J Infect Control Date: 2020-04-10 Impact factor: 2.918
Authors: Pilar I Vidal-Carreras; Julio J Garcia-Sabater; Juan A Marin-Garcia Journal: Int J Environ Res Public Health Date: 2022-04-02 Impact factor: 3.390
Authors: Bassma H Elwakil; Basant A Bakr; Mohammed M Aljeldah; Nourhan S Shehata; Yahya H Shahin; Zakia A Olama; Maria Augustyniak; Mourad A M Aboul-Soud; Abeer El Wakil Journal: Pathogens Date: 2022-08-18
Authors: Thomas Edwards; Shugo Sasaki; Christopher Williams; Glyn Hobbs; Nicholas A Feasey; Katie Evans; Emily R Adams Journal: Sci Rep Date: 2018-01-18 Impact factor: 4.379